Effects of dexamethasone on the expression of fas molecules and apoptosis of lymphocytes in patients with systemic lupus erythematosus

Immunological Investigations

Volumn 30, Issue 3, 2001, Pages 231-243

  Ho, C Y ^a   Wong, C K ^a   Li, E K ^a   Lam, C W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CORTICOSTEROID; DEXAMETHASONE; FAS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD95; APOPTOSIS; CELL CULTURE TECHNIQUES; DEXAMETHASONE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 0034851884     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-100105067     Document Type: Article

References (29)

1. Systemic autoimmune disease arises from polyclonal B cell activation
2. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
3. The role of apoptosis in systemic lupus erythematosus
4. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease
5. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
6. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
7. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes
8. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
9. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
10. The apoptosis-1/Fas protein in human systemic lupus erythematosus
11. In vitro apoptosis and expression of apoptosisrelated molecules in lymphocytes from patients with wystemic lupus erythematosus and other autoimmune diseases
12. Accelerated in vitro apoptosis of lymphocytes from patientswith systemic lupus erythematosus
13. Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus
14. Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis
15. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes
16. The 1982 revised criteria for the classification of systemic lupus erythematosus
17. The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients
18. Guidelines for the evaluation of impairment/di-disability in patients with asthma
19. The role of APO-1-mediated apoptosis in the immune system
20. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
21. Soluble Fas (APO-1 CD95) and soluble Fas ligand in rheumatic diseases
22. Up-regulated expression of fas antigen (CD95) by peripheral naive and memory t cell subsets in patients with systemic lupus erythematosus (SLE): A possible mechanism for lymphopenia
23. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: A review
24. Inverse expression of bcl-2 protein and fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes
25. FAP-1: A protein tyrosine phosphatase that associates with Fas
26. Controlling cell death
27. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by fas antigen engagement
28. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration
29. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus